Anemia Treatment Market Share

Statistics for the 2023 & 2024 Anemia Treatment market share, created by Mordor Intelligence™ Industry Reports. Anemia Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Anemia Treatment Industry

With several companies present, the market for anemia treatment is competitive. Companies are focusing on developing drugs or therapies to treat anemia. Entry into this market is difficult as the company has to go through stringent regulations. The key players operating in this market are Akebia Therapeutics, Inc.; Bluebird Bio, Inc.; GSK plc; Pieris Pharmaceuticals, Inc.; Sanofi; Takeda Pharmaceutical Company Limited; AbbVie, Inc. (Allergan Plc); Pharmacosmos A/S; Pfizer, Inc. (Global Blood Therapeutics, Inc.); and Covis Pharma GmbH (AMAG Pharmaceuticals, Inc.).

Anemia Treatment Market Leaders

  1. Sanofi

  2. AbbVie Inc. (Allergan Plc)

  3. Pharmacosmos A/S

  4. Covis Pharma GmbH (AMAG Pharmaceuticals, Inc.)

  5. Pfizer Inc. (Global Blood Therapeutics, Inc.)

*Disclaimer: Major Players sorted in no particular order

Anemia Treatment Market Concentration

Anemia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)